转移性肺癌中的结痂和糜烂斑块。 - Suppr

Suppr

超能文献

Crusted and eroded plaques in metastatic lung cancer.

作者信息

Wang Robin, Zahirsha Zisansha, Zelman Brandon, Speiser Jodi, Dahiya Madhu, Eilers David

机构信息

Division of Dermatology, Loyola University Medical Center, Maywood, Illinois.

Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, Illinois.

出版信息

JAAD Case Rep. 2024 Nov 9;55:19-22. doi: 10.1016/j.jdcr.2024.10.018. eCollection 2025 Jan.

DOI:10.1016/j.jdcr.2024.10.018

PMID:39691729

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11650259/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/11650259/b44959f002e9/gr1.jpg

相似文献

Crusted and eroded plaques in metastatic lung cancer.转移性肺癌中的结痂和糜烂斑块。

JAAD Case Rep. 2024 Nov 9;55:19-22. doi: 10.1016/j.jdcr.2024.10.018. eCollection 2025 Jan.

Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report.转移性肾细胞癌患者停用免疫检查点抑制剂后疾病持久控制且并发难治性大疱性类天疱疮：一例报告。

Front Immunol. 2022 Sep 16;13:984132. doi: 10.3389/fimmu.2022.984132. eCollection 2022.

A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.一例纳武利尤单抗诱导的大疱性类天疱疮：程序性细胞死亡蛋白 1/程序性死亡配体 1 抑制剂相关皮肤毒性的综述及诊断与管理建议。

Oncologist. 2018 Oct;23(10):1119-1126. doi: 10.1634/theoncologist.2018-0128. Epub 2018 Jul 17.

Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.免疫检查点抑制剂相关的大疱性皮肤免疫相关不良事件：一项多中心观察性研究。

Br J Dermatol. 2022 Dec;187(6):981-987. doi: 10.1111/bjd.21836. Epub 2022 Sep 6.

A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report.一例继发于免疫治疗的药物性大疱性类天疱疮，使用乌帕替尼治疗：病例报告。

SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231160926. doi: 10.1177/2050313X231160926. eCollection 2023.

Case Report: A Presentation of Early-Onset Immune-Mediated Bullous Pemphigoid in a Patient with Urothelial Cancer.病例报告：一位患有膀胱癌的患者出现早发性免疫介导性大疱性类天疱疮。

Curr Oncol. 2023 Aug 23;30(9):7802-7809. doi: 10.3390/curroncol30090566.

Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature.与抗程序性细胞死亡蛋白1和抗程序性细胞死亡配体1治疗相关的大疱性类天疱疮：文献综述

Acta Derm Venereol. 2021 Jan 20;101(1):adv00377. doi: 10.2340/00015555-3740.

Delayed Onset of Bullous Pemphigoid Secondary to Nivolumab.纳武单抗继发大疱性类天疱疮的延迟发作

Cureus. 2023 Aug 9;15(8):e43230. doi: 10.7759/cureus.43230. eCollection 2023 Aug.

A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors.大疱性类天疱疮作为免疫检查点抑制剂不良反应的单机构回顾性研究经验

Cancers (Basel). 2022 Nov 5;14(21):5451. doi: 10.3390/cancers14215451.

Anti-PD1 immune checkpoint inhibitor-induced bullous pemphigoid in metastatic melanoma and non-small cell lung cancer.抗 PD-1 免疫检查点抑制剂引起的转移性黑色素瘤和非小细胞肺癌大疱性类天疱疮。

Cutis. 2020 Jun;105(6):E9-E12.

本文引用的文献

Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience.接受免疫治疗的癌症患者中的自身免疫性大疱性皮肤病：文献综述及意大利多中心经验

Front Med (Lausanne). 2023 Jul 20;10:1208418. doi: 10.3389/fmed.2023.1208418. eCollection 2023.

Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic Review.癌症患者接受免疫检查点抑制剂治疗与大疱性类天疱疮的关联：一项系统评价。

JAMA Dermatol. 2022 Aug 1;158(8):933-941. doi: 10.1001/jamadermatol.2022.1624.

Immune checkpoint inhibitor-related dermatologic adverse events.免疫检查点抑制剂相关的皮肤不良反应。

J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23.

Management of immune checkpoint inhibitor-induced bullous pemphigoid.免疫检查点抑制剂诱导的大疱性类天疱疮的管理。

J Am Acad Dermatol. 2021 Feb;84(2):540-543. doi: 10.1016/j.jaad.2020.05.045. Epub 2020 May 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验